Dr. Doty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1237 Harding Pl
Ste 3200
Charlotte, NC 28204Phone+1 704-355-5375Fax+1 704-355-9241
Summary
- Dr. Doty is board certified in internal medicine, pulmonary disease and critical care medicine. He is currently the medical director of the Lung Cancer Screening Program and the Incidental Lung Nodule Program at Atrium Health. Dr. Doty performed the first endobronchial ultrasound procedure at Atrium Health Carolinas Medical Center and the first electromagnetic navigational bronchoscopy. He has been named a Charlotte Magazine Top Doctor for multiple years.
Education & Training
- Medical University of South CarolinaFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
- University of TennesseeResidency, Internal Medicine/Pediatrics, 1996 - 2000
- University of Tennessee Health Science Center College of MedicineClass of 1996
Certifications & Licensure
- NC State Medical License 2007 - 2025
- SC State Medical License 2002 - 2025
- TN State Medical License 1998 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2009-2012
Publications & Presentations
PubMed
- 234 citationsTreatment of Sarcoidosis With InfliximabJohn D. Doty, Joseph E Mazur, Marc A. Judson
Chest. 2005-03-01 - 27 citationsFatality related to a 30-g venlafaxine overdose.Joseph E Mazur, John D. Doty, Ashley S. Krygiel
Pharmacotherapy. 2003-12-01 - 88 citationsTreatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen.John D. Doty, Joseph E Mazur, Marc A. Judson
Chest. 2003-11-01
Press Mentions
- ‘We Are Very, Very Cautious’: What Endemic COVID May Look like for High-Risk PeopleJanuary 22nd, 2022
- Atrium Health Doctors Use Artificial Intelligence and Robots to Help Detect Lung Cancer EarlyJune 18th, 2021
- New Robot and Software Help Diagnose Lung CancerJune 15th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: